Professional
Added to YB: 2024-09-11
Pitch date: 2024-08-30
BAX [bullish]
Baxter International Inc.
-54.94%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States.
Market Cap
$8.6B
Pitch Price
$36.95
Price Target
N/A
Dividend
0.24%
EV/EBITDA
7.64
P/E
-9.51
EV/Sales
1.46
Sector
Health Care Equipment and Supplies
Category
value
Show full summary:
Broyhill Asset Management Portfolio Holding: Baxter International Inc.
BAX: Healthcare co. w/ critical-care products. Q2 earnings beat, guidance raised. Kidney care sale announced. Consensus skeptical pre-separation. Trading at <12x FY25 E, vs peers at 20x. 4-5% organic growth potential. Position increased. Upside if core biz growth recognized.
Read full article (1 min)